We are live on ! Find out more
BFG

Bleakley Financial Group Portfolio holdings

AUM $6.39B
1-Year Est. Return 26.33%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$41.5M
Cap. Flow
+$24.4M
Cap. Flow %
0.74%
Top 10 Hldgs %
29.31%
Holding
1,123
New
87
Increased
503
Reduced
419
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 16.46%
2 Financials 6.7%
3 Healthcare 5.72%
4 Consumer Discretionary 5.38%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLNT
1001
Fluent
FLNT
$102M
$76.4K ﹤0.01%
30,299
TTI icon
1002
TETRA Technologies
TTI
$1.14B
$68.7K ﹤0.01%
19,200
+151
+0.8% +$537
WALD icon
1003
Waldencast
WALD
$222M
$68.6K ﹤0.01%
17,064
-9,233
-35% -$32.4K
COMP icon
1004
Compass
COMP
$8.51B
$67.1K ﹤0.01%
11,475
-1,258
-10% -$7.97K
SLV icon
1005
CALL
iShares Silver Trust
SLV
$28B
$66K ﹤0.01%
63,600
-37,000
-37% -$1.06M
LILAK icon
1006
Liberty Latin America Class C
LILAK
$1.63B
$64.9K ﹤0.01%
+11,261
New +$81.7K
CLOV icon
1007
Clover Health Investments
CLOV
$2.2B
$63K ﹤0.01%
20,000
-90
-0.4% -$322
SB icon
1008
Safe Bulkers
SB
$795M
$61.8K ﹤0.01%
17,305
-3,207
-16% -$13.4K
OLPX
1009
DELISTED
Olaplex Holdings
OLPX
$60.8K ﹤0.01%
35,133
-1,082
-3% -$2.15K
JMIA
1010
Jumia Technologies
JMIA
$737M
$59.8K ﹤0.01%
15,650
NOK icon
1011
Nokia
NOK
$51B
$59.4K ﹤0.01%
13,418
-162
-1% -$722
CMPX icon
1012
Compass Therapeutics
CMPX
$344M
$58K ﹤0.01%
39,993
+28,589
+251% +$47.5K
CXDO icon
1013
Crexendo
CXDO
$223M
$57.5K ﹤0.01%
11,000
EGY icon
1014
Vaalco Energy
EGY
$570M
$56.3K ﹤0.01%
12,885
+387
+3% +$2.06K
VTYX
1015
DELISTED
Ventyx Biosciences
VTYX
$50.6K ﹤0.01%
23,083
+971
+4% +$2.2K
DH icon
1016
Definitive Healthcare
DH
$72M
$50.3K ﹤0.01%
12,233
-4,415
-27% -$19.3K
LYG icon
1017
Lloyds Banking Group
LYG
$89.5B
$50K ﹤0.01%
18,392
+2,619
+17% +$7.48K
LOT
1018
DELISTED
Lotus Technology
LOT
$48.3K ﹤0.01%
+13,376
New +$56.6K
DHC
1019
Diversified Healthcare Trust
DHC
$2.15B
$41.7K ﹤0.01%
18,140
-602
-3% -$1.77K
OABI icon
1020
OmniAb
OABI
$287M
$39.8K ﹤0.01%
11,229
-8,259
-42% -$32.7K
TNGX icon
1021
Tango Therapeutics
TNGX
$4.43B
$39.7K ﹤0.01%
12,849
-1,578
-11% -$7.33K
ARAY icon
1022
Accuray
ARAY
$32M
$39.3K ﹤0.01%
19,833
PGEN icon
1023
Precigen
PGEN
$2.24B
$39.1K ﹤0.01%
34,888
-332
-0.9% -$283
IBRX icon
1024
ImmunityBio
IBRX
$7.51B
$36.1K ﹤0.01%
14,095
-1,848
-12% -$7.7K
ESPR
1025
DELISTED
Esperion Therapeutics
ESPR
$36K ﹤0.01%
16,357

Similar funds

Bleakley Financial Group's Q4 2024 Portfolio in Review

As of Q4 2024, Bleakley Financial Group held 1,123 positions worth $3.32B, up 1.3% from $3.28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bleakley Financial Group's Q4 2024 filing shows 87 new, 503 increased, 419 reduced and 76 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF October: 270,666 shares worth $11.5M. The largest sale was Vanguard Morningstar Large-Cap ETF, an estimated $22M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bleakley Financial Group's largest Q4 2024 buy was FT Vest US Equity Buffer ETF October: 270,666 shares worth $11.5M.
  • Bleakley Financial Group added most to Dimensional US Small Cap ETF in Q4 2024, an estimated $30.1M increase.
  • Bleakley Financial Group's biggest Q4 2024 reduction was Vanguard Morningstar Large-Cap ETF, cutting an estimated $22M.
  • Bleakley Financial Group fully exited ProShares UltraPro QQQ in Q4 2024, selling an estimated $4.28M.
  • Bleakley Financial Group's ten largest holdings make up 29% of its $3.32B portfolio in Q4 2024.
  • Bleakley Financial Group opened 87 new positions and closed 76 in Q4 2024.
  • Bleakley Financial Group's portfolio value rose 1.3% quarter-over-quarter to $3.32B.

Based on Bleakley Financial Group's 13F filing for Q4 2024, filed 27 Jan 2025.